Loading clinical trials...
Loading clinical trials...
The purpose of this study is to determine whether there is a clinically relevant difference in airway leak pressures between the Ambu AuraGain and the Laryngeal Mask Airway (LMA) Supreme.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Ann & Robert H Lurie Children's Hospital of Chicago
NCT07007403 · Supraglottic Airway
NCT06602830 · Airway Management, Supraglottic Airway, and more
NCT06602817 · General Anesthesia, Airway Management, and more
NCT05783128 · Airway Management, Endotracheal Intubation, and more
NCT05201339 · Supraglottic Airway Device, Intubation; Difficult or Failed, and more
Ann & Robert H Lurie Children's Hospital of Chicago
Chicago, Illinois
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions